MIRA Pharmaceuticals, Inc. (MIRA)

MIRA Pharmaceuticals Statistics

Total Valuation

MIRA has a market cap or net worth of $30.85 million. The enterprise value is $30.38 million.

Market Cap	30.85M
Enterprise Value	30.38M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

MIRA has 18.47 million shares outstanding. The number of shares has increased by 20.70% in one year.

Current Share Class	18.47M
Shares Outstanding	18.47M
Shares Change (YoY)	+20.70%
Shares Change (QoQ)	+0.51%
Owned by Insiders (%)	8.83%
Owned by Institutions (%)	5.13%
Float	14.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	21.57
P/TBV Ratio	24.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.86

Current Ratio	12.86
Quick Ratio	11.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -355.82% and return on invested capital (ROIC) is -226.16%.

Return on Equity (ROE)	-355.82%
Return on Assets (ROA)	-193.30%
Return on Invested Capital (ROIC)	-226.16%
Return on Capital Employed (ROCE)	-622.44%
Revenue Per Employee	n/a
Profits Per Employee	-$2.64M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.07% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-27.07%
50-Day Moving Average	1.39
200-Day Moving Average	1.24
Relative Strength Index (RSI)	57.28
Average Volume (20 Days)	3,684,337

Short Selling Information

The latest short interest is 1.20 million, so 6.49% of the outstanding shares have been sold short.

Short Interest	1.20M
Short Previous Month	233,300
Short % of Shares Out	6.49%
Short % of Float	8.38%
Short Ratio (days to cover)	0.38

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.06M
Pretax Income	-12.36M
Net Income	-7.92M
EBITDA	n/a
EBIT	-8.06M
Earnings Per Share (EPS)	-$0.50

Balance Sheet

The company has $1.21 million in cash and n/a in debt, giving a net cash position of $1.21 million or $0.07 per share.

Cash & Cash Equivalents	1.21M
Total Debt	n/a
Net Cash	1.21M
Net Cash Per Share	$0.07
Equity (Book Value)	1.29M
Book Value Per Share	0.08
Working Capital	1.26M

Cash Flow

Operating Cash Flow	-6.14M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MIRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.70%
Shareholder Yield	-20.70%
Earnings Yield	-25.07%
FCF Yield	n/a

Analyst Forecast

The average price target for MIRA is $14.00, which is 738.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	738.32%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2